Dare Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Dare Bioscience

30/03/2023 14:31

* Dare Bioscience Inc  DARE.OQ  reported a quarterly
adjusted loss
of 19 cents​​ per share for the quarter ended in December. The
mean expectation of six analysts for the quarter was for a loss
of 14 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Dare Bioscience Inc's reported EPS for the quarter was a
loss
of 19 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Dare Bioscience Inc shares had risen by 25.3% this
quarter.
    * The company reported a quarterly loss of $15.94 million.
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.14          -0.19          Missed
 Sep. 30 2022      -0.12          -0.08          Beat
 Jun. 30 2022      -0.06          0.00           Beat
 Mar. 31 2022      -0.14          -0.10          Beat